Oct 06, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
Is Nuveen ESG Mid-Cap Growth ETF ( NUMG ) a Strong ETF Right Now?
Smart Beta ETF report for ...
Oct 01, 2025 • Zacks Commentary
BULLISH
HOLX vs. IDXX: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Instruments stocks have likely encountered both Hologic ( HOLX Quick QuoteHOLX - ) and Idexx Laboratories ( IDXX Quick QuoteIDXX - ) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.
Sep 29, 2025 • Zacks Commentary
BULLISH
IDEXX Laboratories Stock Rallies 52.9% YTD: What's Behind the Drive?
IDXX soars 52.9% YTD, fueled by strong CAG Diagnostics growth, global expansion and rising demand for software solutions.
Sep 25, 2025 • Benzinga
SOMEWHAT-BULLISH
What Does the Market Think About IDEXX Laboratories? - IDEXX Laboratories ( NASDAQ:IDXX )
IDEXX Laboratories's ( NYSE: IDXX ) short interest as a percent of float has risen 3.64% since its last report. According to exchange reported data, there are now 2.12 million shares sold short, which is 3.42% of all regular shares that are available for trading.
Sep 18, 2025 • Benzinga
SOMEWHAT-BULLISH
Here's How Much $100 Invested In IDEXX Laboratories 20 Years Ago Would Be Worth Today - IDEXX Laboratories ( NASDAQ:IDXX )
IDEXX Laboratories IDXX has outperformed the market over the past 20 years by 3.35% on an annualized basis producing an average annual return of 12.2%. Currently, IDEXX Laboratories has a market capitalization of $53.12 billion.